FindTrial
Sign In

efficacy of Kantakari and Vasa Lozenges in children with Kasa

A comparative study on efficacy of Kantakari and Vasa lozenges in children with Kasa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031483
Enrollment
60
Registered
2021-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sites Health Condition 2: C00-D49- Neoplasms

Interventions

Intervention1: kantkari lozenges: Dose
7.5gm-15gm (for 5 to 14 years) in divieded tree doses with warm water 7 days Control Intervention1: vasa lozenges: dose
7.5gm -15gm (for 5 to 14 years )in divieded tree doses with warm water 7 days

Sponsors

Datta meghe institute of medical sciences deemed to be university wardha maharashtra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Dignosed patients of kasa between the age of 5 to 14 years presenting with clincal signs and symptoms given parents consent irrespective of gender caste religion socioeconomic background

Exclusion criteria

Exclusion criteria: known cases of pneumonia bronchial asthma bronchiectasis pleurisy tuberculosis maligancyand other systemic diseases with cough

Design outcomes

Primary

MeasureTime frame
decreased irritability of kasaTimepoint: 3rd day and 7th day and during study Follow up post treatment â??14th& 21st day—

Secondary

MeasureTime frame
Changes in Adventitious soundTimepoint: on 21th days—

Countries

India

Contacts

Public ContactSabir Ali

Mahatma gandhi ayurveda college hospital and research centar salod wardha

rbr.226@gmail.com9011058302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026